28 June 2016

Sartorius acquires Intellicyt for $90m

Sartorius said today it has acquired IntelliCyt for $90 million cash, in a deal that expands the buyer’s portfolio into bioanalytics by adding the developer of cell screening platforms for drug discovery. IntelliCyt manufactures and sells integrated instrumentation, software, and reagent solutions designed to facilitate the study of cells and their components. Most recently last week, IntelliCyt partnered with Notable Labs to advance development of a predictive personalized medicine platform using IntelliCyt’s iQue® Screener PLUS platform. Source: Genetic Engineering News 28/6/2016

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).